No info available.

• P1 Teacher of the Year - School of Pharmacy/UTEP (12/01/2020-12/31/2020)

• Ph D in Pharmaceutical Sciences, Seoul National University (2014)
• MS in Pharmaceutical Sciences, Seoul National University (2010)

• Regulatory Roles of Noncoding RNAs in the Progression of Gastrointestinal Cancers and Health Disparities. Cells 11 15 (2022), A Kulkarni, S Gayathrinathan, S Nair, A Basu, Taslim A. Al-Hilal, Sourav Roy.
• Targeting angiogenic growth factors using therapeutic glycosaminoglycans on doppel-expressing endothelial cells for blocking angiogenic signaling in cancer. Biomaterials 283 (2022), Jae W. Choi, X Zhang, Md Hasan, Mohammad A. Karim, S W. Chung, F Alam, F Alqahtani, S Y. Reddy, I S. Kim, Taslim A. Al-Hilal, Y Byun.
• Cancer-on-a-Chip: Models for Studying Metastasis. Cancers 14 3 (2022), X Zhang, Mohammad A. Karim, Md Hasan, J Hooper, R Wahab, Sourav Roy, Taslim A. Al-Hilal.
• Cancer-on-a-Chip: Models for Studying Metastasis. Cancers 14 3 (2022), Xiaojun Zhang , Mazharul Karim, Md M. Hasan , Jacob Hooper, Riajul Wahab , Sourav Roy, Taslim A. Al-Hilal.
• Organ-Chip Models: Opportunities for Precision Medicine in Pancreatic Cancer. Cancers 13 17 (2021), M R. Haque, T H. Rempert, Taslim A. Al-Hilal, C Wang, A Bhushan, F Bishehsari.
• Anticoagulation therapy promotes the tumor immune-microenvironment and potentiates the efficacy of immunotherapy by alleviating hypoxia. Journal for immunotherapy of cancer 9 8 (2021), Jae W. Choi, N K. Lee, H Seo, S W. Chung, Taslim A. Al-Hilal, S J. Park, S Kweon, N Min, S K. Kim, S Ahn, U I. Kim, J W. Park, C Y. Kang, I S. Kim, S Y. Kim, K Kim, Y Byun.
• Design, synthesis and biological evaluations of a long-acting, hypoxia-activated prodrug of fasudil, a ROCK inhibitor, to reduce its systemic side-effects. Journal of controlled release : official journal of the Controlled Release Society 334 (2021), Taslim A. Al-Hilal, M A. Hossain, A Alobaida, F Alam, A Keshavarz, E Nozik-Grayck, K R. Stenmark, N A. German, F Ahsan.
• Delayed Exercise-induced Upregulation of Angiogenic Proteins and Recovery of Motor Function after Photothrombotic Stroke in Mice. Neuroscience 461 (2021), A Al Shoyaib, F F. Alamri, A Biggers, S T. Karamyan, T V. Arumugam, F Ahsan, C M. Mikelis, Taslim A. Al-Hilal, V T. Karamyan.
• Chapter thirTEEN - Bioengineering approach for pulmonary drug delivery Woodhead Publishing (2021), Ali Keshavarz, Hossam Kadry, Ahmed Alobaida, Md Nurunnabi, Taslim A. Al-Hilal.
• Method for Investigating Fibroblast Durotaxis. Methods in molecular biology (Clifton, N.J.) 2299 (2021), H Kadry, D Lagares, Taslim A. Al-Hilal.
• Pulmonary-arterial-hypertension (PAH)-on-a-chip: fabrication, validation and application. Lab on a chip 20 18 (2020), Taslim A. Al-Hilal, A Keshavarz, H Kadry, B Lahooti, A Al-Obaida, Z Ding, W Li , R Kamm, I F. McMurtry, T Lahm, E Nozik-Grayck, K R. Stenmark, F Ahsan.
• Nano-Vesicle Based Anti-Fungal Formulation Shows Higher Stability, Skin Diffusion, Biosafety and Anti-Fungal Efficacy In Vitro. Pharmaceutics 12 6 (2020), I G. Deaguero, M N. Huda, V Rodriguez, J Zicari, Taslim A. Al-Hilal, Badruddoza AZM, Md Nurunnabi.
• Nano-Vesicle Based Anti-Fungal Formulation Shows Higher Stability, Skin Diffusion, Biosafety and Anti-Fungal Efficacy In Vitro. Pharmaceutics 12 6 (2020), I G. Deaguero, M N. Huda, V Rodriguez, J Zicari, Taslim A. Al-Hilal, Badruddoza AZM, Md Nurunnabi.
• Nano-vesicle based Miconazole formulation has higher anti-fungal efficacy Pharmaceutics (2020), Isaac Deaguero, Md Nurul Huda, Victor Rodriguez, Jade Zicari, Taslim A. Al-Hilal, Md Nurunnabi.
• Engineered Nanodelivery Systems to Improve DNA Vaccine Technologies. Pharmaceutics 12 1 (2020), M Lim, Badruddoza AZM, J Firdous, M Azad, A Mannan, Taslim A. Al-Hilal, C S. Cho, Md Nawshad Arslan Islam.
• Repurposing rosiglitazone, a PPAR-γ agonist and oral antidiabetic, as an inhaled formulation, for the treatment of PAH. Journal of controlled release : official journal of the Controlled Release Society 280 (2018), J Rashid, A Alobaida, Taslim A. Al-Hilal, S Hammouda, I F. McMurtry, E Nozik-Grayck, K R. Stenmark, F Ahsan.
• Multi-purposable filaments of HPMC for 3D printing of medications with tailored drug release and timed-absorption. International journal of pharmaceutics 544 1 (2018), H Kadry, Taslim A. Al-Hilal, A Keshavarz, F Alam, C Xu, A Joy, F Ahsan.
• A targeted ferritin-microplasmin based thrombolytic nanocage selectively dissolves blood clots. Nanomedicine : nanotechnology, biology, and medicine 14 3 (2018), Jiwoo Seo, Taslim A. Al-Hilal, J G. Jee, Youngcho Kim, H J. Kim, B H. Lee, S Kim, I S. Kim.

• An ascitic fluid-derived organoid platform for hispanic ovarian cancer patients to capture heterogeneity and disparity (2023), Volume Orlando, Florida, MD Mynul Hassan, SM Riajul Wahab, Sheralyn Sanchez, Eugene Toy, Sireesha Y. Reddy, Sourav Roy, Taslim A. Al-Hilal.
• Bioengineering and precision modeling of Pulmonary Arterial Hypertension (2023), Volume Pittsburg, PA, Taslim A. Al-Hilal.
• Engaging in Interdisciplinarity Panel Discussion with Q&A (2022), Volume El Paso, TX, Guillermina Solis, Thenral Mangadu, Taslim Al-Hilal, Michael Pokojovy, Ivonne Santiago.
• Intratumoral fibrin as a novel immunomodulatory and matrix remodeling factor in pancreatic ductal adenocarcinoma (2022), Volume Chicago, Taslim A. Al-Hilal.
• Targeting Intratumoral Fibrin-clot Improves the Immune Checkpoint Inhibitor Efficacy Against Pancreatic Ductal Adenocarcinoma (2022), Volume Minneapolis, Minnesota, MD Mahedi Hassan, SM Riajul Wahab, Mazharul Karim, Paul Grippo, Faraz Bishehsari, Taslim A. Al-Hilal.
• Intratumoral fibrin as a novel immunomodulatory factor in pancreatic ductal adenocarcinoma (2022), Volume Boston, MA, SM Riajul Wahab, Mazharul Karim, MD Mahedi Hassan, Paul Gripp, Faraz Bishehsari, Taslim A. Al-Hilal.
• The Role of Prion-like Protein “Doppel” in Cancer (2022), Volume El Paso, TX, Taslim A. Al-Hilal.
• Intratumoral Fibrin as a Novel Immunomodulatory Factor in Pancreatic Ductal Adenocarcinoma (2022), Volume Kyoto, Japan, Mazharul Karim, MD Mahedi Hassan, Riajul Wahab, Faraz Bishehsari, Taslim A. Al-Hilal.
• On-chip capturing and enumeration of blood circulating endothelial cells identify the prion-like protein Doppel as a novel target of PAH (2022), Volume Berlin, Germany, Taslim A. Al-Hilal.
• The Prion-like Protein Doppel as a Serum Biomarker for Epithelial Ovarian Cancer (2022), Volume El Paso, TX, Taslim A. Al-Hilal.
• On-chip Capturing of Diseased Circulating Endothelial Cells and its Enumeration to Detect New Biomarkers of Pulmonary Arterial Hypertension (2021), Volume South Korea, Taslim A. Al-Hilal.
• Targeting Durotaxis, a Stiffness-Directed Cell Migration, in Metastatic Pancreatic Cancer (2020), Volume South Korea, Taslim A. Al-Hilal.
• Detection, treatment and bioengineering of cancer and vascular diseases using microfluidic tissue-chips (2020), Volume El Paso, Texas, Taslim A. Al-Hilal.
• Microfluidic Chips for Studying the Pathophysiology, Treatment and Diagnosis of Pulmonary Arterial Hypertension (PAH) (2020), Volume Daegu, South Korea, Taslim A. Al-Hilal.
• Targeting Durotaxis, a Stiffness-Directed Cell Migration, in Metastatic Pancreatic Cancer (2020), Volume Seoul, South Korea , Taslim A. Al-Hilal.
• Circulating Endothelial Cells (CECs) as a Diagnostic Marker and to Identify New Drug Targets for Neonatal PAH. (2019), Volume Chicago, IL, Taslim A. Al-Hilal.

• STTR I: RAPID AND REPROGRAMMABLE ASSAY DEVELOPMENT FOR MULTIPLEXED GENE DETECTION